News

Recipharm has successfully received European Medicines Verification Organisation (EMVO) approval to submit serialisation data to the European Hub. The connection, which was…
Read More...

Paragon BioTeck, a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies,…
Read More...

Boehringer Ingelheim announced that it has acquired all shares of ViraTherapeutics, a biopharmaceutical company specializing in the development of oncolytic viral therapies.…
Read More...

Consort Medical plc announces a significant new contract with Opiant Pharmaceuticals. Opiant is a specialty pharmaceutical company developing pharmacological treatments for addictions…
Read More...

EpimAb Biotherapeutics announced that it has filed an IND for its most advanced therapeutic development candidate EMB01. The applications were simultaneously submitted to the U.S. Food…
Read More...

Cambrex Corporation announced it has completed the acquisition of Halo Pharma (Halo), a leading dosage form Contract Development and Manufacturing Organization (CDMO) located in…
Read More...

Pall Corporation has announced a strategic partnership between its Pall Biotech business unit and Aetos Biologics, a biosimilar cell line development company. The companies will…
Read More...

Casma Therapeutics announced a research collaboration with Fondazione Telethon, founder of the Telethon Institute of Genetics and Medicine (TIGEM), to develop new therapies for…
Read More...

Sherpa Clinical Packaging (Sherpa) has announced an agreement to be acquired by PCI Pharma Services (PCI). Sherpa, headquartered in San Diego, CA, provides clinical trial material…
Read More...

Portola Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the Company’s Prior Approval Supplement (PAS) filing for the…
Read More...

WuXi Biologics and Inhibrx announced that the companies have entered into an exclusive partnership for the GMP manufacturing of certain of Inhibrx's protein-based therapeutics. The…
Read More...

Eyevance Pharmaceuticals announced the acquisition of FRESHKOTE - a family of lubricant eye drops from Focus Laboratories, Inc. Under the terms of the agreement, Eyevance acquired…
Read More...

Global alternative asset manager The Carlyle Group announced that it has acquired a significant minority stake in Ambio Holdings, Inc., a fast-growing global peptide active…
Read More...

BioCryst Pharmaceuticals announced that the Centers for Disease Control and Prevention (CDC) has awarded BioCryst a $34.7 million contract for the procurement of up to 50,000 doses of…
Read More...

Scilex Pharmaceuticals Inc. (Scilex), a subsidiary of Sorrento Therapeutics, Inc. announced data showing ZTlido (lidocaine topical system) 1.8% (ZTlido) demonstrated a statistically…
Read More...

Thermo Fisher Scientific has signed a definitive agreement with BD (Becton, Dickinson and Company) under which Thermo Fisher will acquire BD's Advanced Bioprocessing business. This…
Read More...

AstraZeneca and its partner Amgen Inc. announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tezepelumab in patients with severe…
Read More...

Softbox announces that it is launching its MAX range at the next IQPC Annual Cold Chain Global Forum (24-27 September) in Philadelphia. Softbox’s MAX range is a new addition to the…
Read More...

Gilead Sciences and Galapagos announced that the randomized, placebo-controlled Phase 2 TORTUGA study of filgotinib, an investigational, selective JAK1 inhibitor, achieved its primary…
Read More...

LEO Pharma and Bayer announced the completion of the relevant closing conditions to allow the transfer of Bayer’s prescription dermatology business to LEO Pharma in the United States.…
Read More...